Skip to main content
PLOS One logoLink to PLOS One
. 2021 Mar 4;16(3):e0247766. doi: 10.1371/journal.pone.0247766

Depression and frailty in older adults: A population-based cohort study

Fabiana Araújo Figueiredo Da Mata 1,*,#, Marilia Miranda Forte Gomes 2,#, Jair Lício Ferreira Santos 3,#, Yeda Aparecida de Oliveira Duarte 4,#, Mauricio Gomes Pereira 1,#
Editor: Frank Y Zhan5
PMCID: PMC7932072  PMID: 33662006

Abstract

Background

Studies have shown an association between depression and frailty, even though the literature has not reached a consensus regarding how these syndromes interact. Although prospective cohort studies on this topic are still scarce, they could contribute to understanding this relationship. We aimed to observe whether depressive symptoms are risk factors for the onset of frailty among older adults living in São Paulo, Brazil.

Methods

Prospective cohort study using the “Health, Well-being and Aging” (SABE) Study databases of 2006 and 2010. The sample was representative of the community-dwelling older adults living in São Paulo, and it is composed of non-frail men and women aged 60 years and older without cognitive decline. We calculated the frailty incidence rate between older adults with and without depressive symptoms and calculated the incidence rate ratio. Multiple analysis was carried out through Poisson regression with robust variance estimation.

Results

The initial sample (n = 1,109) presented a mean age of 72 years (from 60 to 96) and 61.1% were women. The final sample was composed of 830 individuals, and the mean follow-up time in the study was 3.8 years. After adjusting the model, depressive symptoms did not predict the onset of frailty at follow-up.

Conclusion

Depressive symptoms were not shown to be a risk factor for frailty among older adults living in São Paulo in this study.

Introduction

Depression and frailty are considered common syndromes among older adults, with prevalence estimates varying from 6.5% to 25.3% for depressive symptomatology and from 4.0% to 59.1% for frailty [15]. Even though depression and frailty are considered two separate conditions/constructs, they share moderate overlap, meaning they can happen concomitantly in an individual [5,6].

Depression and frailty also share several commonalities (e.g., psychomotor slowness, fatigue, and weight change) [6]. Both conditions can increase the likelihood of disabilities and other causes of morbimortality in older adults [5,7]. Cross-sectional studies carried out in many geographic regions have shown some relationship between frailty and depression [812]. Even though similar biological mechanisms, such as subclinical cardiovascular disease and inflammation, have been hypothesized to be responsible for both frailty and depression, evidence to date shows both syndromes as different constructs [5]. However, there is still room for more investigation about the relationship and etiology of frailty and depression.

There is an agreement in the literature that some aspects of frailty are not well understood in the literature. For example, there is no consensus regarding whether physical aspects alone lead to frailty or whether psychosocial aspects also play a role in the syndrome’s definition [13]. While frailty is considered a pure physical syndrome in some studies, other researchers state that psychosocial aspects are important in defining the condition [1416].

The relationship between depressive symptoms and frailty may be bidirectional [17,18]. While there is a probability that people with frailty will develop depression (given their crescent physical limitations and lack of independence), there are cases where depressive symptoms negatively impact the body’s physical functioning and may contribute to the development of frailty [1,19,20]. Although cohort studies help clarify this relationship’s direction, not many studies were found to investigate this in the literature.

Therefore, this study investigates whether depressive symptoms are risk factors for the onset of frailty in older adults living in São Paulo, Brazil.

Methods

Study design

This study uses a prospective cohort design to analyze data collected by the “Health, Well-being and Aging” (SABE) Study, a multicentric survey that aims to investigate the life and health of older adults in seven cities from seven countries in Latin America and the Caribbean (LAC) [21]. Brazil has been collecting data since 2000, every five years on average, as part of this study in São Paulo. Our study estimates and compares the incidence of frailty in two groups of older adults with and without depressive symptoms in two points of time (2006 and 2010) as data were available. We followed the STROBE Statement checklist.

Sampling and sample

This study included men and women aged 60 years and older without cognitive impairment and/or frailty. Data of people with cognitive impairment were excluded because of the existing evidence that cognitive impairment leads to the development of characteristics similar to the frailty syndrome [16], which could overestimate the incidence of frail older adults in this study.

The sample was divided into two groups according to the presence or absence of depressive symptoms (variable of exposure). The exposure group was composed of older adults with depressive symptoms, while the non-exposure group was composed of older adults without depressive symptoms. Information on the sampling process originally used for the SABE Study can be found in Lebrão and Duarte, 2003 [22].

Data in this study were gathered through similar surveys conducted in 2006 and 2010, where physical and self-reported information was collected. The questionnaires used in the surveys are available on the SABE website [23].

Study variables

Exposure variable: Depressive symptoms

Depressive symptoms were defined according to the short version of the Geriatric Depression Scale (GDS) [24,25]. The presence of depressive symptoms was considered when older adults punctuated more than five in the GDS (in such cases, they were assigned to the exposure group). People with five or fewer points on the scale were assigned to the non-exposure group.

Outcome variable: Frailty syndrome

We defined the frailty syndrome variable based on the Fried frailty phenotype, 2001 [16]. The variable was dichotomized into (a) frail and (b) non-frail older adults, where pre-frail and robust older adults were aggregated into the latter variable. To create the outcome variable, we needed to operationalize the five characteristics of the frailty phenotype. This operationalization is described next [16,26].

1. Unintentional weight loss. Older adults who answered that they lost at least 3 kg in the past three months received one point for frailty [27].

2. Exhaustion. Two questions from the Center for Epidemiologic Studies Depression Scale (CES-D) were used [16,28]. When older adults answered “a moderate amount of time (3 to 4 days)” or “the greater part of the time” to at least one of the two questions, they received one point for frailty. 3. Reduced walking speed. We used a question from the SABE questionnaire that recorded the time an older adult needed to walk a 3-meter distance; the maximum amount of time considered to do this was 10 minutes. The walking speed was stratified by sex and height; the cut-off points corresponding to the lowest quintiles are shown in Table 1. People classified in the lowest quintile and those people who could not perform the test were given one point for frailty.

Table 1. Cut-off point for the walking speed test (in seconds) by sex and height.
Sex Mean height (in meters) Cut-off point (in seconds)
Male > 1.65 ≥ 6
≤ 1.65 ≥ 6
Female > 1.52 ≥ 6
≤ 1.52 ≥ 7

4. Low level of physical activity. We used six questions from the International Physical Activity Questionnaire (validated for older Brazilian people in 2007) [29]. The questions refer to frequency and duration of physical activities classified as low, moderate, and high intensities. The calorie loss for each activity was calculated in MET (metabolic equivalent) by multiplying each activity by the number of days per week, time (in minutes), and MET; then the calorie waste was stratified by sex and age group [26]. The calorie waste values were stratified in quintiles; people in the lowest 20% quintile received one point for frailty [16,26]. Therefore, women with calorie waste up to 327.6 Kcal/week, men with calorie waste up to 344.0 Kcal/week and not physically active older adults scored in the frailty range.

5. Reduced handgrip strength. Each individual could carry out the handgrip test with a dynamometer twice. The mean strength for each older person was adjusted by sex and BMI (body mass index). Afterward, the quintiles of grip strength were calculated for each BMI quartile (Table 2). Older people in the lowest (first) quintile of strength received one point for frailty [16,26]. Those who could not perform the test and who could not stand up also received one point for frailty because it was not possible to measure their heights.

Table 2. BMI quartiles adjusted by sex and their respective cut-off points for strength.
Male
Quartiles BMI Muscle strength cut-off point
1 15.24–22.43 20.0
2 22.44–24.61 21.4
3 24.62–27.11 24.0
4 ≥27.12 24.0
Female
Quartiles BMI Muscle strength cut-off point
1 ≤23.14 13.0
2 23.15–26.48 14.0
3 26.49–29.76 14.0
4 ≥29.77 14.0

The outcome variable (frailty syndrome) corresponded to the sum of the punctuation allocated to each of the five characteristics presented above. In the end, an older person could score between zero and five points for the variable frailty syndrome in this study.

Persons with punctuation equal or higher than three (they presented three or more characteristics for frailty syndrome) were classified as frail. Those people who sum to zero, one, or two points were classified as non-frail. According to Fried at al., 2001 [16], there is the pre-frailty stage (when a person presents one or two of the characteristics). However, pre-frailty was not of interest in this study as it was still considered non-frail, so older adults with one or two characteristics were considered robust in this study.

Possible confounding and adjusting variables were selected according to the literature.

Covariables

The selected covariables were based on self-reported answers to the SABE questionnaire in 2006. We assumed that this information was kept constant until (1) the development of frailty, (2) the date of death, or (3) the new data collection in 2010. The variables considered in this study did not present more than 1% of missing values.

The chosen variables to analyze the relationship between depressive symptoms and frailty were the most commonly encountered in the literature as potential confounders of this relationship (30). We selected ten variables of interest and grouped them into sociodemographic (sex, age, marital status, and years of schooling), health information (self-rated health, BMI, number of chronic diseases, number of medications), and lifestyle (smoking and alcohol consumption).

Older adults with cognitive decline were excluded from the sample. The operationalization of this variable was based on the Mini-Mental State Examination–MMSE (punctuation equals or is less than 12) and on the Pfeffer Scale (punctuation higher than 11) [26,3032].

Data analysis

The sampling process in the SABE study is complex; thus we considered this characteristic when analyzing the data. A weight was assigned to each participant according to the census sector to which they belonged. In the descriptive analysis, we compared the basal distribution of the sample characteristics between the exposure and non-exposure groups. We also used mean, standard deviation, and the chi-square test to compare the distributions between both the final sample and the lost to follow-up sample to assess the presence of bias.

In this study, the exposure time to the risk of manifesting frailty varied among the individuals; thus, the variable person-year corresponded to the exposure time in years between the date of the first interview and the manifestation or non-manifestation of frailty or occurrence of death (whichever happened first).

The incidence rate was calculated considering this follow-up time: (a) the time between the first and the second interviews for older adults who did not develop frailty, (b) half of the time between the first and the second interviews for those who developed frailty, and (c) the time between the first interview and the date of death for those who died. The incidence rate ratio was also calculated.

We conducted a univariate analysis and the variables with p-value<0.20 were selected for the multiple model [33]. Covariables known as relevant for the investigated topic were selected regardless of their statistical significance. A multicollinearity test was performed; and when correlations were more than 0.80, we chose one of the variables for not entering the multiple model [34].

A Poisson regression model with robust variance estimation using the backward regression method was chosen for the multiple analysis [35]. We considered the time of exposure to the risk of developing frailty (person-year) in the multiple model. A binomial regression test was also conducted [35].

Covariables with p-value < 0.20 in the univariate analysis entered the multiple model. However, covariables were kept in the model when they (a) presented p-value<0.05, or (b) adjusted the incidence rate ratio in at least 10%, or (c) were important for the studied outcome or, (d) improved the quality of the final model. We used the link test to check the model adjustment [36]. Calculations were performed with their respective 95% confidence intervals (95%CI) and the significance level of 5%. The software Stata® 13.0 was used for statistical analyses.

Results

Sample selection

This study initially included men and women aged 60 years and older (n = 1,413 in 2006). However, we excluded from this sample older adults who presented cognitive impairment and/or frailty in 2006 (n = 280) and those with missing information about these two variables (n = 14). As a result of these exclusions, in 2006 there were 1,119 non-frail older adults without cognitive decline in the sample. After excluding missing values related to depressive symptoms, the initial sample included 1,109 non-frail older adults aged 60 to 96. Fig 1 shows the flowchart representing the sample selection process in this study.

Fig 1. Flowchart of the sample selection process.

Fig 1

After the follow-up time,—out of the 1,109 individuals who initiated in the study– 830 survived until 2010, there were 124 who died, and 155 were lost (54 individuals were not located, 33 moved to other municipalities, 6 were institutionalized, and 62 refused to continue in the study; totalizing around 14% of lost follow-up). We considered data from 858 individuals for calculating incidence in this study (734 surviving older adults who had information about frailty at the end of 2010 and 124 non-surviving older adults).

Sample characteristics

The initial sample (n = 1,109) presented a mean age of 72 years (from 60 to 96 years old) and 61.1% were women. Table 3 shows basal characteristics from the two groups: people with depressive symptoms and people without depressive symptoms in 2006. The distribution pattern was similar in both groups, except for the majority of older adults with depressive symptoms who self-rated their health as regular, had fewer years of education and used more medication compared with older adults without depressive symptoms.

Table 3. Characteristics of groups exposed and non-exposed to depressive symptoms.

Adjustment variables With depressive symptoms, n = 142 Without depressive symptoms, n = 967 p-value
Number of observations % Number of observations %
A. Sociodemographic:
Sex
 Female 107 75.3 571 59 <0.001
 Male 35 24.6 396 40.9
Age group (years)
 60–69 71 50 428 44.3 0.436
 70–79 42 29.6 323 33.4
 80 and older 29 20.4 216 22.3
Marital status
 With partner 70 49.3 516 53.4 0.358
 Without partner 72 50.7 451 46.6
Years of schooling 0
 4 or more 62 43.7 580 60 <0.001
 Less than 4 80 56.3 387 40
B. Health Information
Self-rated health
 Very good and good 21 14.7 503 52 <0.001
 Regular 87 61.4 422 43.6
 Poor and very poor 34 24 32 3.3
BMI
 Normal 63 44.3 409 42.3 0.563
 Underweight 28 20 233 24.1
 Overweight and obesity 51 35.7 325 33.6
Number of chronic diseases
 None 16 11.3 172 17.8 <0.001
 1 or 2 69 48.6 564 58.3
 3 or more 57 40.1 231 23.9
Number of used medication
 None 6 4.2 95 9.8 <0.001
 1 to 3 50 35.2 435 45
 4 or more 86 60.6 436 45.1
C. Lifestyle
Smoking
 Never smoked 69 48.6 518 53.6 <0.001
 Former smoker 39 27.5 352 36.4
 Current smoker 34 24 97 10
Alcohol consumption 0
 No 133 93.7 913 94.4 0.717
 Yes 9 6.3 54 5.6

Note—The sample size was 1,109 in all variables, apart from the following: marital status (n = 1,108), number of medications used (n = 1,108) and BMI (n = 1,090).

Table 4 shows a comparison between the final sample (composed of individuals alive in 2010, n = 830) and the loss to follow-up sample plus non-surviving people (n = 279). In this study, the lost to follow-up sample represented a higher proportion of men, smokers and former smokers, underweight people and people older than 80. The mean follow-up time in the study was 3.8 years.

Table 4. Comparison between the final sample (survivals in 2010) and the lost to follow-up sample.

Variables Final sample in 2010, n = 830 Lost to follow up sample, n = 279 p-value
Number of observations % Number of observations %
A. Sociodemographic:
Sex
 Female 531 64 147 52.7 <0.001
 Male 299 36 132 47.3
Age group (years)
 60–69 401 48.3 98 35.1 <0.001
 70–79 280 33.7 86 30.8
 80 and older 150 18.1 95 34
Marital status
 With partner 445 53.6 142 50.9 0.441
 Without partner 385 46.4 137 49.1
Years of schooling
 4 or more 486 58.5 156 55.9 0.44
 Less than 4 344 41.5 123 44.1
B. Health information:
Self-rated health
 Very good and good 401 48.3 123 44.1 0.27
 Regular 377 45.4 132 47.3
 Poor and very poor 52 6.3 24 8.6
BMI
 Normal 357 43 116 41.4 <0.001
 Underweight 170 20.5 91 32.7
 Overweight and obesity 304 36.6 72 25.8
Number of chronic diseases
 None 141 17 47 16.8 0.465
 1 or 2 466 56.1 167 59.9
 3 or more 223 26.9 65 23.3
Number of medications used
 None 79 9.5 22 7.9 0.325
 1 to 3 353 42.5 133 47.5
 4 or more 398 48 124 44.6
C. Lifestyle
Smoking
 Never smoked 461 55.5 126 45.2 0.009
 Former smoker 279 33.6 112 40.1
 Current smoker 90 10.8 41 14.7
Alcohol consumption
 No 789 95 257 92.1 0.066
 Yes 41 4.9 22 7.9

Note—The sample size was 1,109 in all variables, apart from the following: marital status (n = 1,108), number of medications used (n = 1,108) and BMI (n = 1,090).

Incidence of frailty, univariate and multiple analyses

Among the depressive symptoms group, 12.6% of people were frail in 2010, the incidence rate (IR) was 16.4 thousand person-years (95%CI: 8.4;36.4), and the total of person-years was 444,645.5. Among older adults without depressive symptoms, the frequency of frailty in 2010 was 9.8%, the incidence rate was 12.7 thousand person-years (95%CI: 9.6;17.2) and the total of person-years was 2,997,256.5. The frailty incidence rate ratio (IRR) between individuals with and without depressive symptoms was 1.29 (95%CI: 1.26;1.32) and the total of person-years 3,441,902.1.

In the univariate analysis, five out of ten investigated variables were selected to the multiple model (Table 5): more advanced ages, living without a partner, self-rated health as regular, being overweight, and presenting three or more chronic diseases. The variables of sex and years of schooling were selected given their importance in the literature, even though they were not statistically significant. There was no multicollinearity among variables selected for the multiple model.

Table 5. Univariate analysis among covariables and the risk of frailty.

Variables Incidence ratio Confidence Interval (95%) p-value
A. Sociodemographic:
Sex
 Male 1 0.880
 Female 0.96 (0.57–1.62)
Age group (years)
 60–69 1
 70–79 2.61 (1.47–4.62) <0.001
 80 and older 4.94 (2.93–8.33) <0.001
Marital status
 With partner 1
 Without partner 1.54 (0.89–2.64) 0.114
Years of schooling
 4 or more 1
 Less than 4 1.35 (0.77–2.35) 0.277
B. Health information
Self-rated health
 Very good and good 1
 Regular 1.62 (0.99–2.65) 0.056
 Poor and very poor 1.54 (0.54–4.40) 0.411
BMI
 Normal 1
 Underweight 0.89 (0.39–2.05) 0.796
 Overweight and obesity 1.52 (0.81–2.87) 0.186
Number of chronic diseases
 None 1
 1 or 2 1.36 (0.58–3.20) 0.470
 3 or more 2.01 (0.75–5.35) 0.160
Number of medications used
 None 1
 1 to 3 0.58 (0.18–1.80) 0.346
 4 or more 1.3 (0.45–3.72) 0.617
C. Lifestyle
Smoking
 Never smoked 1
 Former smoker 0.89 (0.49–1.63) 0.725
 Current smoker 1.01 (0.39–2.62) 0.974
Alcohol consumption
 No 1
 Yes 0.61 (0.13–2.86) 0.531

Note—The sample size was 1,109 in all variables, apart from the following: marital status (n = 1,108), number of medications used (n = 1,108) and BMI (n = 1,090).

The incidence rate ratio in this study showed that older adults with depressive symptoms presented a 29% greater risk of developing frailty than older adults without these symptoms (IRR = 1.29; 95%CI: 1.26;1.32). Estimates from the adjusted multiple model showed the IRR = 1.21 (95%CI: 0.62;2.36), see Table 6. The link test resulted in a p-value equal to 0.772, indicating a good adjustment of the chosen model.

Table 6. Frailty unadjusted and adjusted incidence rate ratio in the groups with and without depressive symptoms (n = 735).

Depressive symptoms Frailty Unadjusted ratio (95%CI)* Adjusted ratio** (95%CI)*
Yes No
N % N %
Yes 12 1.6 83 11.3 1.29 (1.26;1.32) 1.21 (0.62;2.36)
No 63 8.6 577 78.5

* 95%CI: 95% Confidence Interval.

** Adjusted by sex, age, schooling and number of chronic diseases.

Discussion

This study investigated the hypothesis that depressive symptoms are risk factors for frailty. The results showed a higher onset of frailty among older adults with depressive symptoms compared with those without these symptoms. However, after adjusting the model, depressive symptoms did not predict frailty’s onset over an average of 3.8 years of follow-up.

A controversy in the literature concerns which conceptual model frailty belongs to. While some researchers affirm frailty has physical and psychological origins [14], others support the idea that frailty is purely a physical condition [16]. The results of this study seem to agree with the definition that frailty is a purely physical syndrome since, after adjusting the model, depressive symptoms did not appear to be risk factors for the onset of frailty. In addition, it is well known that depression and frailty are correlated and sometimes they are considered as the same condition [37], but as separate constructs. In this context, the findings of this study may: (a) support the hypothesis that depression and frailty are concurrent conditions in which one could be a component of the other. Even though depression has not been identified as a risk factor for frailty, they may occur concomitantly in individuals. (b) There is a need to further investigate frailty as a risk factor for depression.

Our findings agree with the results of the following investigations. The majority of the cohort studies included in a systematic review pointed out depression as a risk factor for frailty in the unadjusted analysis; however, after adjustment, the relationship between the studies disappeared [38]. Depressive symptoms did not seem to influence the incidence of frailty in a prospective cohort study conducted in the United States since there was no difference in the incidence of frailty between depressive women and negatively affected women [39]. As a consequence of the lack of consensus toward the definition of frailty, it is usual to find the terms “physical limitation”s and “functional disabilities” as synonymous with the frailty syndrome. In this sense, a panel study from the United States investigated the direction of the relationship between depressive symptoms and physical limitations over three years. The authors concluded that depressive symptoms had not been shown as risk factors for physical limitation, although the inverse relationship has been observed [40].

On the other hand, depressive symptoms have been associated with incident frailty in some investigations. A cohort study carried out with 40,659 older women in 40 clinical centers over three years in the United States showed a positive association between depressive symptoms and incident frailty [41]. Cohort studies included in a systematic review also observed that the incidence of frailty varied directly according to the severity of depression [5]. According to a prospective cohort study conducted in the United States, women with positive affect towards life presented half of the risk of manifesting frailty compared with women with negative affect [39]. Similarly, researchers observed that positive affect was associated with reducing the risk of manifesting frailty among African American women [42].

Differences in the definitions and methodological approaches adopted by researchers may influence the outcomes we found in the literature. Data from an American prospective cohort revealed that depression increased the risk of frailty when frailty was classified in a broader definition that involved physical, nutritional, cognitive, and sensorial dimensions [43].

Some studies have also investigated depressive symptoms as risk factors for conditions related to or considered to be similar to frailty, such as functional decline [44,45]. For instance, cohort data from an American study (nine years of follow-up) pointed out a high level of depressive symptoms as risk factors for moderate and severe functional decline, mainly among older women [46].

Study limitations and strengths

Our study has several limitations. We used the variable depressive symptoms, which is not the same as analyzing depressive disorders and their different degrees of severity. Thus the results of this paper need to be interpreted with caution. Using the cut-off point for the variable weight loss as 3kg does not seem to be appropriated as 3kg may represent different body proportions according to each individual’s weight. Instead of using a fixed number of kilograms, a percentage of weight loss in the past year (e.g., 5%) could be used.

In this study, the impossibility of reassessments over the follow-up time prevented us from controlling for potential interchanges between the exposure and non-exposure groups, even though this limitation is known to be a problem inherent to many cohort studies. It was also not possible to gather information about the presence of depressive symptoms in other moments of life. Therefore, the study’s information relates to the health status of each individual during data collection.

Another limitation is that some of the data were self-reported, and this might have introduced bias and lesser accurate information. A possible sample selectivity bias hampered that the variable basic activities of daily living was considered for the chosen model in the study. Furthermore, the lack of consensus in the literature on whether frailty and difficulty in carrying out basic activities of daily living are or are not the same condition may have contributed to inconsistent results found in some statistical tests in this study (S1 and S2 Tables). Therefore, the variable basic activities of daily living was not considered in this study.

The lack of statistical significance in the final regression model may be due to the small number of cases in the study sample. The potential presence of residual confounding requires caution when interpreting the results. Another point is that the loss of follow-up was proportionally higher among people aged 80 and older compared with the initial sample. At the same time, this is the age group with the highest incidence ratio for frailty in the univariate analysis. Therefore, had this loss to follow-up not happened, there could have been room for a higher incidence rate ratio in this study. Finally, the study’s external validity is limited, as our findings only refer to the population of São Paulo.

On the other hand, prospective cohort studies investigating this theme are scarce in the literature. Therefore, our findings may present more robust information from a country experiencing an accelerated ageing process that is in need of investigations. This study uses a formal definition of frailty to allow more precise comparisons of its results with the literature. It also was conducted with a representative sample of older adults living in the city of São Paulo, a city with the highest absolute number of older adults in Brazil and with the most diverse older population, as a result of the national and international immigration process [21].

In this study, depressive symptoms were not considered risk factors for the onset of frailty among older adults living in São Paulo. This result may support the theory that frailty is a physical syndrome instead of a multidimensional condition. There is room for more studies on this topic with larger and more diverse populations in Brazil and abroad.

Supporting information

S1 Table. Poisson multiple regression model: Initial and final models by the backward regression method.

(DOCX)

S2 Table. Poisson multiple regression model considering the variable basic activities of daily living: Initial and final models, by the backward regression method.

(DOCX)

Acknowledgments

We thank the SABE study’s principal investigator and coordenator Maria Lucia Lebrao, in memoriam.

Data Availability

The data underlying the results presented in the study are available from SABE, at http://hygeia3.fsp.usp.br/sabe/.

Funding Statement

This work was supported by the São Paulo Research Foundation - FAPESP, under the number 99/05125-7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Collard RM. Depression and frailty in later life [Internet]. [Holland]: Utrecht University; 2010 [cited 2019 Dec 19]. file:///Users/fabianadamata/Downloads/Frailty%20and%20depression%20in%20later%20life%20(1).pdf
  • 2.Barua A, Ghosh MK, Kar N, Basilio MA. Prevalence of depressive disorders in the elderly. Ann Saudi Med. 2011. December;31(6):620–4. 10.4103/0256-4947.87100 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Mata FAFD, da Pereira PPS, de Andrade KRC, Figueiredo ACMG, Silva MT, Pereira MG. Prevalence of Frailty in Latin America and the Caribbean: A Systematic Review and Meta-Analysis. PLOS ONE. 2016. August 8;11(8):e0160019. 10.1371/journal.pone.0160019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Collard RM, Boter H, Schoevers RA, Oude Voshaar RC. Prevalence of frailty in community-dwelling older persons: a systematic review. J Am Geriatr Soc. 2012. August;60(8):1487–92. 10.1111/j.1532-5415.2012.04054.x [DOI] [PubMed] [Google Scholar]
  • 5.Vaughan L, Corbin AL, Goveas JS. Depression and frailty in later life: a systematic review. Clin Interv Aging. 2015. December 15;10:1947–58. 10.2147/CIA.S69632 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Mezuk B, Lohman M, Dumenci L, Lapane KL. Are depression and frailty overlapping syndromes in mid- and late-life? A latent variable analysis. Am J Geriatr Psychiatry Off J Am Assoc Geriatr Psychiatry. 2013. June;21(6):560–9. 10.1016/j.jagp.2012.12.019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Almeida OP, Hankey GJ, Yeap BB, Golledge J, Norman PE, Flicker L. Depression, frailty, and all-cause mortality: a cohort study of men older than 75 years. J Am Med Dir Assoc. 2015. April;16(4):296–300. 10.1016/j.jamda.2014.10.023 [DOI] [PubMed] [Google Scholar]
  • 8.Ní Mhaoláin AM, Fan CW, Romero-Ortuno R, Cogan L, Cunningham C, Kenny R-A, et al. Frailty, depression, and anxiety in later life. Int Psychogeriatr. 2012. August;24(8):1265–74. 10.1017/S1041610211002110 [DOI] [PubMed] [Google Scholar]
  • 9.Collard RM, Comijs HC, Naarding P, Oude Voshaar RC. Physical frailty: vulnerability of patients suffering from late-life depression. Aging Ment Health. 2014. July;18(5):570–8. 10.1080/13607863.2013.827628 [DOI] [PubMed] [Google Scholar]
  • 10.Sánchez-García S, Sánchez-Arenas R, García-Peña C, Rosas-Carrasco O, Avila-Funes JA, Ruiz-Arregui L, et al. Frailty among community-dwelling elderly Mexican people: prevalence and association with sociodemographic characteristics, health state and the use of health services. Geriatr Gerontol Int. 2014. April;14(2):395–402. 10.1111/ggi.12114 [DOI] [PubMed] [Google Scholar]
  • 11.Sousa ACP de A, Dias RC, Maciel ÁCC, Guerra RO. Frailty syndrome and associated factors in community-dwelling elderly in Northeast Brazil. Arch Gerontol Geriatr. 2012. April;54(2):e95–101. 10.1016/j.archger.2011.08.010 [DOI] [PubMed] [Google Scholar]
  • 12.Chang SS, Weiss CO, Xue Q-L, Fried LP. Patterns of comorbid inflammatory diseases in frail older women: the Women’s Health and Aging Studies I and II. J Gerontol A Biol Sci Med Sci. 2010. April;65(4):407–13. 10.1093/gerona/glp181 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Lally F, Crome P. Understanding frailty. Postgrad Med J. 2007. January;83(975):16–20. 10.1136/pgmj.2006.048587 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Gobbens RJJ, Luijkx KG, Wijnen-Sponselee MT, Schols JMGA. In search of an integral conceptual definition of frailty: opinions of experts. J Am Med Dir Assoc. 2010. June;11(5):338–43. 10.1016/j.jamda.2009.09.015 [DOI] [PubMed] [Google Scholar]
  • 15.Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet Lond Engl. 2013. March 2;381(9868):752–62. 10.1016/S0140-6736(12)62167-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001. March;56(3):M146–156. 10.1093/gerona/56.3.m146 [DOI] [PubMed] [Google Scholar]
  • 17.Bergman H, Ferrucci L, Guralnik J, Hogan DB, Hummel S, Karunananthan S, et al. Frailty: an emerging research and clinical paradigm—issues and controversies. J Gerontol A Biol Sci Med Sci. 2007. July;62(7):731–7. 10.1093/gerona/62.7.731 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Taylor MG, Lynch SM. Trajectories of impairment, social support, and depressive symptoms in later life. J Gerontol B Psychol Sci Soc Sci. 2004. July;59(4):S238–246. 10.1093/geronb/59.4.s238 [DOI] [PubMed] [Google Scholar]
  • 19.Buigues C, Padilla-Sánchez C, Garrido JF, Navarro-Martínez R, Ruiz-Ros V, Cauli O. The relationship between depression and frailty syndrome: a systematic review. Aging Ment Health. 2015;19(9):762–72. 10.1080/13607863.2014.967174 [DOI] [PubMed] [Google Scholar]
  • 20.Ormel J, Rijsdijk FV, Sullivan M, van Sonderen E, Kempen GIJM. Temporal and reciprocal relationship between IADL/ADL disability and depressive symptoms in late life. J Gerontol B Psychol Sci Soc Sci. 2002. July;57(4):P338–347. 10.1093/geronb/57.4.p338 [DOI] [PubMed] [Google Scholar]
  • 21.Lebrão ML, Duarte YA de O, Santos JLF, da Silva NN. 10 Years of SABE Study: background, methodology and organization of the study. Rev Bras Epidemiol. 2019. February 4;21:e180002. 10.1590/1980-549720180002.supl.2 [DOI] [PubMed] [Google Scholar]
  • 22.Lebrão ML, Duarte YA de O, Pan American Health Organization, editors. O Projeto SABE no município de São Paulo: uma abordagem inicial. 1a ed. Brasília, DF, Brasil: Organização Pan-Americana de Saúde, OPAS/OMS; 2003. 255 p.
  • 23.University of São Paulo. SABE- Saúde, Bem-estar e Envelhecimento [Internet]. SABE- Saúde, Bem-estar e Envelhecimento. 2020. http://hygeia3.fsp.usp.br/sabe/quetionario.php
  • 24.Almeida OP, Almeida SA. Confiabilidade da versão brasileira da Escala de Depressão em Geriatria (GDS) versão reduzida. Arq Neuropsiquiatr. 1999. June;57(2B):421–6. 10.1590/s0004-282x1999000300013 [DOI] [PubMed] [Google Scholar]
  • 25.Greenberg SA. The Geriatric Depression Scale (GDS). Hartford Inst Geriatr Nurs. (4):2.
  • 26.Panes VCB. Adaptação dos componentes da síndrome de fragilidade e avaliação da fragilização dos idosos residentes no município de São Paulo: estudo SABE saúde, bem-estar e envelhecimento [Internet] [Mestrado em Enfermagem na Saúde do Adulto]. [São Paulo]: Universidade de São Paulo; 2011 [cited 2019 Dec 19]. http://www.teses.usp.br/teses/disponiveis/7/7139/tde-25022011-111802/
  • 27.de Duarte YAO, Nunes DP, de Andrade FB, Corona LP, de Brito TRP, dos Santos JLF, et al. Frailty in older adults in the city of São Paulo: Prevalence and associated factors. Rev Bras Epidemiol [Internet]. 2018. [cited 2019 Dec 19];21. http://www.scielo.br/scielo.php?script=sci_abstract&pid=S1415-790X2018000300418&lng=en&nrm=iso&tlng=pt [DOI] [PubMed] [Google Scholar]
  • 28.Batistoni SST, Neri AL, Cupertino APFB. Validade da escala de depressão do Center for Epidemiological Studies entre idosos brasileiros. Rev Saúde Pública. 2007. August;41(4):598–605. 10.1590/s0034-89102007000400014 [DOI] [PubMed] [Google Scholar]
  • 29.Benedetti TRB, Antunes P de C, Rodriguez-Añez CR, Mazo GZ, Petroski ÉL. Reprodutibilidade e validade do Questionário Internacional de Atividade Física (IPAQ) em homens idosos. Rev Bras Med Esporte. 2007. February;13(1):11–6. [Google Scholar]
  • 30.Icaza MG, Albala C. Minimental State Examinations (MMSE) del estudio de demencia en Chile: análisis estadístico [Internet]. Minimental State Examinations (MMSE) del estudio de demencia en Chile: análisis estadístico. 1999 [cited 2019 Dec 19]. http://www.paho.org/spanish/hdp/hdr/serie07composite.pdf
  • 31.Pfeffer RI, Kurosaki TT, Harrah CH, Chance JM, Filos S. Measurement of functional activities in older adults in the community. J Gerontol. 1982. May;37(3):323–9. 10.1093/geronj/37.3.323 [DOI] [PubMed] [Google Scholar]
  • 32.Mayo AM. Use of the Functional Activities Questionnaire in Older Adults with Dementia. Hartford Inst Geriatr Nurs. 2016;D13:2. [Google Scholar]
  • 33.Paes ÂT. Análise univariada e multivariada. Einstein Educ Contin Em Saúde. 2010;(8):2.
  • 34.Hamilton LC. Statistics with Stata: updated version 9. Canada: Thomson Books; 2006. [Google Scholar]
  • 35.Long JS, Freese J. Regression Models for categorical dependent varables. 6th ed. Texas: Stata Press Publication; 2001. [Google Scholar]
  • 36.Pregibon D. Goodness of Link Tests for Generalized Linear Models. J R Stat Soc Ser C. 1980;29(1):15–24. [Google Scholar]
  • 37.Lohman M, Dumenci L, Mezuk B. Depression and Frailty in Late Life: Evidence for a Common Vulnerability. J Gerontol B Psychol Sci Soc Sci. 2016;71(4):630–40. 10.1093/geronb/gbu180 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Mezuk B, Edwards L, Lohman M, Choi M, Lapane K. Depression and frailty in later life: a synthetic review. Int J Geriatr Psychiatry. 2012. September;27(9):879–92. 10.1002/gps.2807 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Park-Lee E, Fredman L, Hochberg M, Faulkner K. Positive affect and incidence of frailty in elderly women caregivers and noncaregivers: results of Caregiver-Study of Osteoporotic Fractures. J Am Geriatr Soc. 2009. April;57(4):627–33. 10.1111/j.1532-5415.2009.02183.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Gayman MD, Turner RJ, Cui M. Physical Limitations and Depressive Symptoms: Exploring the Nature of the Association. J Gerontol B Psychol Sci Soc Sci. 2008. July;63(4):S219–28. 10.1093/geronb/63.4.s219 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Woods NF, LaCroix AZ, Gray SL, Aragaki A, Cochrane BB, Brunner RL, et al. Frailty: emergence and consequences in women aged 65 and older in the Women’s Health Initiative Observational Study. J Am Geriatr Soc. 2005. August;53(8):1321–30. 10.1111/j.1532-5415.2005.53405.x [DOI] [PubMed] [Google Scholar]
  • 42.Ostir GV, Ottenbacher KJ, Markides KS. Onset of frailty in older adults and the protective role of positive affect. Psychol Aging. 2004. September;19(3):402–8. 10.1037/0882-7974.19.3.402 [DOI] [PubMed] [Google Scholar]
  • 43.Strawbridge WJ, Shema SJ, Balfour JL, Higby HR, Kaplan GA. Antecedents of frailty over three decades in an older cohort. J Gerontol B Psychol Sci Soc Sci. 1998. January;53(1):S9–16. 10.1093/geronb/53b.1.s9 [DOI] [PubMed] [Google Scholar]
  • 44.Penninx BW, Guralnik JM, Ferrucci L, Simonsick EM, Deeg DJ, Wallace RB. Depressive symptoms and physical decline in community-dwelling older persons. JAMA. 1998. June 3;279(21):1720–6. 10.1001/jama.279.21.1720 [DOI] [PubMed] [Google Scholar]
  • 45.Bruce ML. Depression and disability in late life: directions for future research. Am J Geriatr Psychiatry Off J Am Assoc Geriatr Psychiatry. 2001;9(2):102–12. [PubMed] [Google Scholar]
  • 46.Barry LC, Allore HG, Bruce ML, Gill TM. Longitudinal association between depressive symptoms and disability burden among older persons. J Gerontol A Biol Sci Med Sci. 2009. December;64(12):1325–32. 10.1093/gerona/glp135 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Frank Y Zhan

29 Dec 2020

PONE-D-20-35568

Depression and frailty in older adults: a population-based cohort study

PLOS ONE

Dear Dr. Da Mata,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Feb 12 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Yiqiang Zhan

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Need to specify numbers and percentage for each variables not only percentage.

-the p value in the final sample should be for each variable to identify significant confounders in logistic regression

- Alphabetical and grammatical adjustment.

Reviewer #2: It is a cohort study that was correctly delineated and conducted. The authors controlled the possible confounding variables and performed the correct statistical treatment. The limitations of the study were clearly presented.There is a small error on page 9, line 194, the value 1119 should be corrected to 1129 (1423 - 280 -14). As the only suggestion I would recommend the inclusion of a comment on the possible impact of the loss of segment of individuals aged 80 and over. The loss in this segment was proportionally higher and at the same time it is the age group with the highest incidence ratio in the univariate analysis.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Mar 4;16(3):e0247766. doi: 10.1371/journal.pone.0247766.r002

Author response to Decision Letter 0


28 Jan 2021

Reviewer #1

1) Need to specify numbers and percentage for each variables not only percentage.

Reply: Thank you for your comment. We included numbers in the tables where the information was missing (Table 3 and Table 4).

2) The p value in the final sample should be for each variable to identify significant confounders in logistic regression.

Reply: We have added the p-values to the regression tables in the Supporting Information (S1 Table and S2 Table).

3) Alphabetical and grammatical adjustment.

Reply: Thank you for the suggestion. The paper has been reviewed by a professional English proofreader, who has revised the writing of the paper.

Reviewer #2

1) There is a small error on page 9, line 194, the value 1119 should be corrected to 1129 (1423 - 280 -14).

Reply: Thank you for this comment. When revising the paper, we noticed that the error refers to a typo in the sample size, which should be 1,413 instead of 1,423. We have changed this in the line 273.

2) As the only suggestion I would recommend the inclusion of a comment on the possible impact of the loss of segment of individuals aged 80 and over. The loss in this segment was proportionally higher and at the same time it is the age group with the highest incidence ratio in the univariate analysis.

Reply: We thank you for this suggestion. We have added a discussion of this point in the line 531.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Frank Y Zhan

15 Feb 2021

Depression and frailty in older adults: a population-based cohort study

PONE-D-20-35568R1

Dear Dr. Da Mata,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Frank Y Zhan

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: regarding the manuscript "Depression and frailty in older adults: a population-based cohort study"PONE-D-20-35568R1 i accept for publication.

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Acceptance letter

Frank Y Zhan

22 Feb 2021

PONE-D-20-35568R1

Depression and Frailty in Older Adults: A Population-Based Cohort Study

Dear Dr. Da Mata:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Frank Y Zhan

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Poisson multiple regression model: Initial and final models by the backward regression method.

    (DOCX)

    S2 Table. Poisson multiple regression model considering the variable basic activities of daily living: Initial and final models, by the backward regression method.

    (DOCX)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    The data underlying the results presented in the study are available from SABE, at http://hygeia3.fsp.usp.br/sabe/.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES